Jerzy Gumulka - Apr 10, 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-Fact
Stock symbol
CNSP
Transactions as of
Apr 10, 2023
Transactions value $
$5,308
Form type
4
Date filed
4/17/2023, 08:17 AM
Previous filing
Jul 16, 2021
Next filing
Apr 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $5.31K +7.17K $0.74 7.17K Apr 10, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.